← FDA DRUG APPROVALS

FDA ANDA · ANDA065324

AMOXICILLIN

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA065324
TYPE
ANDA
ORIGINAL APPROVAL
2007-01-17
LATEST ACTION
2014-12-02
ROUTE
ORAL
DOSAGE FORM
TABLET, FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 200MG · TABLET, FOR SUSPENSION · ORAL
AMOXICILLINDiscontinued
AMOXICILLIN 400MG · TABLET, FOR SUSPENSION · ORAL

Approval history

2014-12-02Labeling · Supplement 6AP
2007-01-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →